Pilot study by Luis F. Garcia, MD & Bryan L. Frank, MD
Global Mission Partners, Inc
Abstract
Malaria remains a foremost concern in Kenya, with high mortality and morbidity rates despite standard treatment. Malaria is transmitted by Anopheles mosquitoes in humans and is caused by Plasmodium parasites. The present pilot investigation presents the potential of biomagnetism as a therapeutic approach in malaria patients in Kisumu, Kenya.
Sixty voluntary participants from a charitable clinic in Kisumu, Kenya, underwent diagnostic evaluations. Seven participants were confirmed positive Plasmodium falciparum infection. All these participants elected biomagnetism as the sole therapeutic intervention. Six returned for follow-up after three days: Five exhibited parasitological clearance and absolute symptom resolution. And one of them demonstrated initial reduced parasitemia and improved clinical status before achieving clearance following the second biomagnetism session.
These findings align with prior pilot study investigations, including Dr. Brian Frank’s study on typhoid fever, suggesting that biomagnetism may warrant as an adjunctive therapeutic modality in infectious management. The study was coordinated through the Missionary Foundation Global Mission Partners, Inc. as a self funded initiative.
Introduction
Malaria is a vector- borne infectious disease caused by Plasmodium parasite that infects the female Anopheles mosquito, which then feeds on humans. The clinical manifestations present with high- grade fever, flu- like symptoms, rigors, and in severe cases, jaundice and multi- organ involvement.
The disease is of great global significance and of considerate burden.
- In fact, in 2021, malaria accounted for an estimated 247 million clinical cases worldwide, with 619,000 deaths, disproportionately affecting the African Region (95% of cases, 96% of deaths). Approximately 80% of malaria-related mortality in this region occurs in children under five years.
- In the United States, approximately 2,500 malaria cases are reported annually, predominantly among travelers and immigrants returning from endemic areas.
Conventional treatment approaches include pharmacological (anti- malarial drugs) approach with drugs such as chloroquine, quinine, and artemisinin-based therapy. However, the limitations such as limited accessibility, drug resistance, socioeconomic constraints highlights the need for a complementary therapeutic strategy.
Biomagnetic Pair Therapy (BPT) or Biomagnetism works on the usage of medium- strength magnets that are placed in pairs with opposite polarities on specific parts of the body. The goal is to restore the optimal or natural pH of organs and tissues. This state is known as homeostasis, and it is at this range where the body can heal itself effectively.
Against this backdrop, we present to you the findings from a pilot study on the application of biomagnetism in malaria.
Methodology
Study Site and Participants
- The pilot study was conducted in a charitable clinic serving the rural community on the outskirts of Kisumu, Kenya.
- A total of 60 voluntary participants presented for malaria testing. None of them had previously sought treatment for this febrile illness.
Diagnostics
Two diagnostic modalities were incorporated in the Kenyan pilot study.
- Blood Smear Microscopy: Blood smears were stained for visualization of the parasitemia. Two thick and two thin smears were included for diagnostic evaluation.
- Rapid Diagnostic Tests (RDTs): Antigen- detection assays detect the specific antigens produced by Plasmodium falciparum and other species.
Choice of Treatment and Intervention
- Of the 60 participants, seven of them tested positive for Plasmodium falciparum.
- Each participant was given the choice of treatment between conventional or biomagnetic pair therapy. Significantly, all of these participants opted for biomagnetism.
Biomagnetic Pairs Applied
The magnetic pairs identified for malaria in this cohort study included:
Results
- Follow-up Cohort: Six of the seven malaria- positive participants returned for evaluation three days post-intervention.
- Parasitological Clearance: Five of the six exhibited negative results on blood smear, rapid diagnostic tests, and their symptoms showed absolute resolution.
- Partial Clearance: One out of the six participants tested positive at follow-up but demonstrated minimized parasite density and improved clinical presentation. Following a second session of biomagnetism, both microscopy and RDT results were negative, and clinical symptoms resolved within an additional three days.
- Overall outcome: All the six participants achieved (who attended follow-up) complete parasitological clearance with symptomatic resolution without any pharmacological intervention.
Discussion
The pilot study offered potential therapeutic effects of biomagnetism in malaria. The symptomatic recovery and parasitological clearance in all six follow-up participants highlights the consideration within the broader context of infectious disease management.
Comparison to Prior Research
- These findings are consistent with results from Dr. Brian Frank’s pilot study on typhoid fever which was conducted in Kenya.
- In that study, 13 participants tested positive for Salmonella typhi via Widal test. Out of 13 participants, 10 exhibited negative results within two days following biomagnetism.
- This highlights the potential reproducibility of biomagnetism therapy in clinical impact across infectious diseases.
Potential Mechanisms
- The core principle of Biomagnetism Therapy works on the usage of medium- strength magnets that are placed in pairs with opposite polarities on specific parts of the body, thereby disrupting microbial viability.
- The goal is to restore the optimal or natural pH of organs and tissues. This state is known as homeostasis, and it is at this range where the body can heal itself effectively.
- Thereby rectifying these local pH imbalances, Biomagnetism helps eliminate the pathogen environments and supports the body’s immune system.
- The repetitive identification of the specific anatomical pairs suggests the reproducibility in therapeutic targeting.
Future Directions
- Small sample size (n=7 malaria-positive cases).
- Lack of a control group receiving conventional treatment.
- Dependence on voluntary follow-up (one patient did not return).
- Absence of quantitative parasitemia measurements beyond positive/negative assays.
Future Directions
- Rigorous randomized controlled trials will give us further direction, established efficacy, mechanism of action, and reproductivity. Integration of this therapeutic approach with conventional therapies will help explore and assess the potential synergistic benefits.
- The non-invasiveness, low- cost nature makes it relevant for underserved populations.
Conclusion
- This self- funded pilot study, coordinated through the Missionary foundation Global Mission Partners, Inc. showcases an early attempt to evaluate biomagnetism as a therapeutic modality for malaria.
- Conducted in Kisumu, Kenya, it demonstrated complete parasitological clearance and symptom resolution in all follow-up participants without the use of pharmacological agents.
- While limited by scale and design, these findings contribute to the emerging academic reputation of biomagnetism and provide justification for more extensive investigations into its role in infectious disease therapy.